Dublin, June 23, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/kr...ll_banking ) has announced the addition of the "Stem Cell Banking Market in India 2015-2019" report to their offering. The stem cell banking market in India to grow at a CAGR of 37.85% over the period 2014-2019. This report covers the present scenario and the growth prospects of the stem cell banking market in India for the period 2015-2019. To calculate the market size, the report considers revenue generated by stem cell banking service providers. It presents the vendor landscape and corresponding detailed analysis of the top six vendors in the market. The report provides the segmentation of the market based on type of products, applications, and type of banks.
Leading stem cell private banks in India have set up sales forces within their organizations where trained medical representatives visit potential customers' homes and educate them about the concept, collection, and processing. The introduction and implementation of any new medical concept in India gains credibility among the public through the involvement of doctors. Therefore, private players have established a marketing and sales force structure in association with pharmaceutical companies, which can obtain information about the population of pregnant women from obstetricians and gynecologists on a regular basis. Small and regional banks are incorporating these sales force structures and are developing the required infrastructure through private funding. Some banks directly approach possible customers to sell their concepts. According to the report, India has the potential to become the largest source of umbilical cord cells because of the increasing birth rate. As a result, leading stem cell banking companies are eyeing India as a new hub for investment. A large number of private organizations and high-end hospital chains have ventured into regenerative medicine, which utilizes stem cells from placentas, umbilical cords, aborted fetuses, and menstrual blood to treat a broad range of diseases. Further, the report states that one of the challenges the market faces is a lack of awareness about the potential benefits of the storage of stem cells. Key Vendors
- CordLife Sciences India
- Cryobanks International India
- LifeCell International
- Reliance Life Sciences
- Stempeutics Research
- Tran-Scell Biologics
Other Prominent Vendors
- CordCare
- Cryo Save India
- Cryo Stemcell
- International Stem Cell
- Jeevan Blood Bank Research Centre
- NovaCord
- Reelabs
- RMS Regrow
- Stemade Biotech
- StemCyte India Therapeutics
- StemOne Biologicals
- StemRx BioScience Solutions
For more information visit http://www.researchandmarkets.com/research/kr...ll_banking
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology, Stem Cells
